Netflix remains the streaming sector's clear leader, with robust financials and a pioneering business model that continues to drive growth. Current valuation multiples, including a P/E of 38.7x, are below five-year averages, presenting a compelling entry point for long-term investors.

Indian equities are poised for a constructive phase, with strategists anticipating earnings acceleration and a potential revival in foreign investor interest. While near-term earnings surprises are limited, FY27 is projected to see significant growth. Pharma stands out for valuation support and visible pipelines.

All over the world, travelers are seeking out authentic hotels firmly rooted in their environs and boasting a unique vibe. Casa Yuma in Puerto Escondido exemplifies this barefoot luxury trend, blending local culture with modern amenities to attract high-spending guests.

Tottenham Hotspur’s search for attacking reinforcements has taken a familiar Premier League turn, with Brentford forward Igor Thiago emerging as a target amid a hot striker market.

While near-term market direction remains uncertain, Anshul Saigal emphasizes a long-term perspective, highlighting India's strong growth and macro stability. He anticipates accelerating earnings growth and sees attractive opportunities in sectors like IT, metals, and consumer goods.

Amid Liverpool's push for midfield reinforcements, Richard Hughes may be overlooking long-term fit, risking another costly oversight. The club's selection choices hint at deeper strategic missteps.

Greece’s early repayment of €5.3 billion to official creditors eases future budgetary pressure, cuts interest burdens for companies, and could lower borrowing costs for households. The move signals fiscal discipline and restores investor confidence.

Projected demand for data centres of 5.8GW would exceed Ireland’s 2030 offshore wind target of 5GW, forcing regulators to secure extra power. The scramble highlights opportunities in new transmission lines and renewable infrastructure.

Corona Remedies shares rose sharply after a blockbuster IPO debut. Strong institutional demand, consistent profitability, and a focused chronic therapy portfolio underpin the momentum, even as the stock trades at a modest premium.

Shares of Kaynes Technology rebounded sharply after a prolonged correction, supported by positive brokerage views from Elara Capital. Recent accounting concerns appear overstated, leaving the long-term growth story intact.

AI adoption in European banks is set to supercharge earnings, blending old-line lending with next-gen technology. The convergence offers a rare sectoral sweet spot for investors seeking growth and stability.

Despite significant headwinds, M&A activity in beauty accelerated across categories in 2025. Smaller brands with strong digital footprints attracted private equity and strategic buyers looking for differentiated assets.

Wakefit Innovations listed at Rs 195 on the NSE and Rs 194.1 on the BSE, reflecting a flat listing relative to its IPO price. Market response suggests tempered expectations despite solid business fundamentals.

Corona Remedies opened with a 38.42% premium, reflecting robust investor appetite. The oversubscribed Rs 655 crore offer for sale underscores confidence in its chronic therapy portfolio.

Jefferies initiated coverage with a Buy rating and Rs 660 target, citing record silver prices and cost efficiency. Robust cash generation and disciplined capital allocation underscore the bullish thesis.